Molecular basis for the antigenicity of lidocaine analogs: Tocainide and mexiletine
- 31 March 1984
- journal article
- case report
- Published by Elsevier in American Heart Journal
- Vol. 107 (3) , 585-589
- https://doi.org/10.1016/0002-8703(84)90105-4
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTIONThe Lancet, 1980
- Tocainide therapy for refractory ventricular arrhythmiasAmerican Heart Journal, 1980
- MexiletinePublished by American Medical Association (AMA) ,1979
- Long-term oral antiarrhythmic therapy with mexiletine.Heart, 1978
- Long-term tocainide therapy for ventricular arrhythmias.Circulation, 1978
- Toxic Effects of Local AnestheticsPublished by American Medical Association (AMA) ,1978
- Suppression of ventricular ectopic depolarizations by tocainide.Circulation, 1977
- Antiarrhythmic effects of a lidocaine congener, tocainide, 2‐amino‐2',6'‐propionoxylidide, in manClinical Pharmacology & Therapeutics, 1976
- Long-term treatment of ventricular arrhythmias with oral mexiletineAmerican Heart Journal, 1976
- Group Specificity of Epidermal Allergy to Procaine in Man1Journal of Investigative Dermatology, 1945